In Memoriam: Asal Sayas
Asal Sayas (1983-2026) was a respected public policy expert, cancer advocate, and former White House advisor whose work focused on advancing cancer research, public health, and patient care. She passed away on April 21, 2026, at the age of 42 after a six-year battle with young-onset colorectal cancer.
Throughout her career, Sayas held several influential positions in government and healthcare policy. She served as Senior Advisor for Infectious Disease and Cancer in the White House under President Joe Biden, where she contributed to the Cancer Moonshot initiative aimed at reducing cancer mortality and improving the lives of patients nationwide. Prior to this role, she led government affairs at amfAR, the Foundation for AIDS Research, and worked with Senator Amy Klobuchar and Representative Andre Carson on Capitol Hill.
In January 2025, Sayas joined the Colorectal Cancer Alliance as a consultant, dedicating the final months of her life to advocating for increased federal funding for colorectal cancer research. Drawing from her own experience as a stage IV colorectal cancer patient, she became a powerful voice for young adults facing the disease and worked tirelessly to promote earlier diagnosis, better treatment options, and greater awareness. Colleagues, medical professionals, and public leaders remembered Sayas as an intelligent strategist, compassionate advocate, and inspiring leader whose determination transformed personal adversity into meaningful change. Her contributions to cancer policy, research advocacy, and patient support leave a lasting legacy that continues to inspire the healthcare and public policy communities.
Tributes and Remembrances
Following the passing of Asal Sayas, colleagues and advocates from across the public health and policy community honored her life and legacy, highlighting her lasting impact on cancer advocacy and young adult oncology.
Ibrahim Halil Sahin shared a personal tribute from a congressional memorial event, describing Sayas as a dear friend whose life was devoted to advancing progress for patients, especially those affected by young-onset colorectal cancer. He emphasized her passion, compassion, and unwavering commitment to helping others, noting that her influence extended far beyond her immediate professional roles. Sahin also reflected on the continuation of her legacy through legislative efforts such as the Asal Sayas Young Adult Cancer Act, describing it as a testament to the lasting impact she made on both policy and people. He concluded his tribute with a personal farewell, honoring her kindness, courage, and determination.
Together, these reflections underscore Asal Sayas’s extraordinary legacy as a policy leader, advocate, and friend. Her work not only shaped national conversations around cancer care but continues to inspire ongoing efforts to improve outcomes for young adults facing cancer.

Aparna Parikh reflected on Sayas’s profound influence during a congressional ceremony dedicated to advancing a national strategy for young adult cancers. She described the moment as both powerful and deeply meaningful, noting that Sayas’s vision and advocacy directly contributed to the development of the Asal Sayas National Strategy for Young Adult Cancers. Parikh emphasized that Sayas’s work had ‘profound and far-reaching’ impact, bringing together policymakers, medical leaders, and advocacy organizations in pursuit of systemic change. She also noted the urgency of continuing this work, stating that while the initiative marks an important step forward, ‘so much more remains to be done‘ to ensure young adults with cancer receive the support they deserve.

James Coburn honored Sayas as a dedicated colleague and tireless advocate, recalling their shared work on cancer drug shortages and systemic healthcare challenges. He described her as ‘an amazing person and colleague’ who worked relentlessly to improve complex and often ineffective systems affecting cancer patients. Coburn highlighted her commitment to patient advocacy and her determination to create meaningful improvements for those navigating serious illness, particularly within oncology care.
Other articles featuring Asal Sayas on OncoDaily.